Ulland Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$1K 245
2023
Q4
$1K Sell
50
-22
-31% -$299 ﹤0.01% 195
2023
Q3
$1K Hold
72
﹤0.01% 208
2023
Q2
$1K Hold
72
﹤0.01% 208
2023
Q1
$2K Hold
72
﹤0.01% 190
2022
Q4
$2K Sell
72
-25
-26% -$639 ﹤0.01% 197
2022
Q3
$2K Hold
97
﹤0.01% 202
2022
Q2
$3K Hold
97
﹤0.01% 227
2022
Q1
$3K Hold
97
﹤0.01% 242
2021
Q4
$3K Buy
+97
New +$3.16K ﹤0.01% 198

Other funds holding OGN

Ulland Investment Advisors's OGN Position: Q1 2024 in Review

Ulland Investment Advisors sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 50 shares — an estimated $1K sold.

Ulland Investment Advisors first reported a position in OGN in Q4 2021 and held it in 9 quarters. The position peaked at $3K in Q2 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Ulland Investment Advisors reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Ulland Investment Advisors sold 50 Organon & Co shares in Q1 2024, an estimated $1K.
  • Ulland Investment Advisors first reported a position in Organon & Co in Q4 2021 and held it in 9 quarters.
  • Ulland Investment Advisors's Organon & Co position peaked at $3K in Q2 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Ulland Investment Advisors's 13F filing for Q1 2024, filed 25 Apr 2024.